ACSL1 and hepatocellular carcinoma: Supporting these findings, in vitro experiments demonstrated that HULC activates ACSL1 expression in HepG2 hepatoma cells via the miRNA-9/PPARA signaling pathway, thereby inducing lipid metabolic reprogramming that facilitates HCC progression.